Chemoinformaics analysis of geranylgeranyl diphosphate
| Molecular Weight | 450.449 | nRot | 14 |
| Heavy Atom Molecular Weight | 414.161 | nRig | 8 |
| Exact Molecular Weight | 450.194 | nRing | 0 |
| Solubility: LogS | -3.046 | nHRing | 0 |
| Solubility: LogP | 2.224 | No. of Aliphatic Rings | 0 |
| Acid Count | 3 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 65 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 29 | No. of Aromatic Carbocycles | 0 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 36 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 70.2785 |
| nHD | 3 | BPOL | 57.0035 |
| QED | 0.232 |
| Synth | 4.428 |
| Natural Product Likeliness | 1.002 |
| NR-PPAR-gamma | 0.015 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.895 |
| Pgp-sub | 0.007 |
| HIA | 0.867 |
| CACO-2 | -5.361 |
| MDCK | 0.0000368 |
| BBB | 0.755 |
| PPB | 0.967533 |
| VDSS | 0.446 |
| FU | 0.0144698 |
| CYP1A2-inh | 0.016 |
| CYP1A2-sub | 0.084 |
| CYP2c19-inh | 0.037 |
| CYP2c19-sub | 0.048 |
| CYP2c9-inh | 0.135 |
| CYP2c9-sub | 0.987 |
| CYP2d6-inh | 0.018 |
| CYP2d6-sub | 0.139 |
| CYP3a4-inh | 0.016 |
| CYP3a4-sub | 0.029 |
| CL | 1.477 |
| T12 | 0.802 |
| hERG | 0.002 |
| Ames | 0.002 |
| ROA | 0.001 |
| SkinSen | 0.98 |
| Carcinogencity | 0.445 |
| EI | 0.907 |
| Respiratory | 0.81 |
| NR-Aromatase | 0.001 |
| Antiviral | Yes |
| Prediction | 0.77678 |